Page last updated: 2024-08-24

cilazapril, anhydrous and Chronic Kidney Diseases

cilazapril, anhydrous has been researched along with Chronic Kidney Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Knap, N; Larczynski, W; Neuwelt, A; Petranyuk, A; Renke, M; Rutkowski, B; Rutkowski, P; Tylicki, L; Wozniak, M	1

Trials

1 trial(s) available for cilazapril, anhydrous and Chronic Kidney Diseases

Article	Year
High-dose angiotensin-converting enzyme inhibitor attenuates oxidative stress in patients with chronic kidney disease. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2009, Volume: 24, Issue:2 Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cilazapril; Cross-Over Studies; Dinoprost; Drug Therapy, Combination; Female; Humans; Isoprostanes; Male; Oxidative Stress; Renal Insufficiency, Chronic; Renin-Angiotensin System; Telmisartan	2009

Article

Year

High-dose angiotensin-converting enzyme inhibitor attenuates oxidative stress in patients with chronic kidney disease.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2009, Volume: 24, Issue:2

Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cilazapril; Cross-Over Studies; Dinoprost; Drug Therapy, Combination; Female; Humans; Isoprostanes; Male; Oxidative Stress; Renal Insufficiency, Chronic; Renin-Angiotensin System; Telmisartan

2009